Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
11/26/2007
1.
Phase III Randomized Study of Clodronate for Locally Advanced Adenocarcinoma of the Prostate
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
over 18
MRC-PR04
EU-94032
Last Modified:
3/8/2005
2.
Phase III Randomized Double-Blind Study of Clodronate vs Placebo in Patients with Prostate Cancer Metastatic to Bone Who Are Commencing or Responding to Initial Hormone Therapy (Summary Last Modified 03/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
any age
MRC-PR05
EU-94033
Last Modified:
6/20/2008
 
First Published:
4/1/1998
3.
Phase III Randomized Study of Mitoxantrone and Prednisone With or Without Clodronate in Patients with Hormone Refractory Metastatic Prostate Cancer and Pain
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Closed
Any age
CAN-NCIC-PR6
NCT00003232, PR6
Last Modified:
4/11/2005
 
First Published:
2/1/2001
4.
Phase III Randomized Study of Adjuvant Clodronate With or Without Systemic Chemotherapy and/or Hormonal Therapy in Women With Early Stage Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
Not specified
NCI
NSABP-B-34
SWOG-NSABP-B-34, NCCTG-NSABP-B-34, NCT00009945, NSABP-B-34
Last Modified:
7/1/1994
5.
Phase III Randomized Study of Clodronate vs Placebo during Initial Therapy with DOX/BCNU/CTX/L-PAM (ABCM) in Patients with Previously Untreated Multiple Myeloma and of IFN-A Maintenance Therapy vs No Maintenance During First Plateau
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Closed
under 75
MRC-LEUK-MYEL-INF
EU-92025
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute